Physician profile
Clay E Morgan
NPI 1417189465
$893.94
in general payments reported to CMS, 2019-2025
13 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $267 · 2024: $16.74 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $147.11 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $144.19 | 2022-2025 | Gamma, Mako, Tornier Perform Reversed Glenoid |
| Curonix LLC | $107.46 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $95.71 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $90.79 | 2022-2025 | Euflexxa |
| Vericel Corporation | $85.30 | 2022 | |
| Pacira Therapeutics, INC. | $66.68 | 2021 | |
| Midsouth Orthopedics INC. | $53.21 | 2021-2022 | |
| Baudax Bio INC. | $30.63 | 2022 | |
| Horizon Therapeutics Plc | $29.31 | 2021 | |
| Convatec INC. | $17.01 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $13.64 | 2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clay Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.